Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition.
Saved in:
| Title: | Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition. |
|---|---|
| Authors: | Lee JH; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia.; Chris O'Brien Lifehouse, Camperdown, NSW, Australia., Shklovskaya E; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Lim SY; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Carlino MS; Melanoma Institute Australia, Sydney, NSW, Australia.; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, NSW, Australia., Menzies AM; Melanoma Institute Australia, Sydney, NSW, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia., Stewart A; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Pedersen B; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Irvine M; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Alavi S; Melanoma Institute Australia, Sydney, NSW, Australia.; Melanoma Oncology and Immunology, Centenary Institute, Camperdown, NSW, Australia., Yang JYH; School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Strbenac D; School of Mathematics and Statistics, The University of Sydney, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia., Saw RPM; Melanoma Institute Australia, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Thompson JF; Melanoma Institute Australia, Sydney, NSW, Australia.; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Wilmott JS; Melanoma Institute Australia, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Scolyer RA; Melanoma Institute Australia, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia., Long GV; Melanoma Institute Australia, Sydney, NSW, Australia.; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia., Kefford RF; Macquarie University, Sydney, NSW, Australia.; Melanoma Institute Australia, Sydney, NSW, Australia., Rizos H; Macquarie University, Sydney, NSW, Australia. helen.rizos@mq.edu.au.; Melanoma Institute Australia, Sydney, NSW, Australia. helen.rizos@mq.edu.au. |
| Source: | Nature communications [Nat Commun] 2020 Apr 20; Vol. 11 (1), pp. 1897. Date of Electronic Publication: 2020 Apr 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
